West Health’s Post

Reigning In Out of Control Drug Costs Our special guest Wendy Barnes, CEO of RxBenefits, Inc. and Mark Campbell, the VP of #RxBenefits. Health care spending in the United States has increased substantially the past few years, and it isn't likely to slow down any time soon. At this rate, national health care costs could reach $6.2 trillion by 2028. A number of factors, including the cost of medical supplies and drugs, contribute to those rising numbers. The financial pinch many people were already feeling has been intensified by the unsteady economy, leading consumers to call for lowered health plan costs whenever and wherever possible. Some believe reducing prescription drug spending is an easy way to do that. But consumers still deserve access to the medications they need at prices they can afford. (from BenefitsPRO) Listen here: https://lnkd.in/eQ3XdXRK

Learn more about the 2023 EULAR recommendations and what these may mean for your patients with #Lupus. Listen to this podcast presented by Dr. Narender Annapureddy #SponsoredbyGSKUSMA

Learn more about the 2023 EULAR recommendations and what these may mean for your patients with #Lupus. Listen to this podcast presented by Dr. Narender Annapureddy #SponsoredbyGSKUSMA

We're talking about Medicare Part D drug negotiation results on tomorrow's show. 🔮 What did we predict a year ago and how does that compare to now? Subscribe so you can find out: https://lnkd.in/dAgvX8eH

🎙️ New Episode Alert! 🚨 Tune into The Drug Report Podcast as Luke Niforatos & Dr. Kevin Sabet dive into this week's pivotal drug policy news & events. https://lnkd.in/evprzrJz Plus, don't miss the latest updates on SAM & FDPS' impactful events across Europe and at the UN. 🌍💡 Stay informed. Listen now! #DrugPolicy #SAMFDPSUpdates

Spread The Word

Hey #Pharmacists! Feeling the pressure of medication errors, staffing gaps, and regulatory juggling? You're not alone. But here's some good news! Introducing the #PrimeRx Pharmacy Podcast Trends, your partner in navigating today's #pharmacy challenges and thriving in the digital era. Learn more here: https://lnkd.in/ep9sTR9q

Late in 2023 the FDA put a hold on the enforcement of the Drug Supply Chain Security Act. Unfortunately, too many pharmacy owners thought that meant they could relax. Not so according to two industry experts. In this podcast they explain the delay in enforcement was necessary because too many companies were not ready to comply. Now, with more time to prepare it is hoped pharmacies will work with their suppliers and get ready to meet the requirement's. In this podcast information is shared as to what that means. And, remember, the clock is still ticking to Nov. 2024.   This episode is brought to you by The HDA - Healthcare Distribution Alliance, sometimes better knows and, HDA. This organization helps serve the needs of distributors, and wholesalers, who supply medications and healthcare products. HDA works closely with government agencies and their corporate members to ensure products are safely stored and distributed. They are intimately involved with the Drug Supply Chain Security Act, or #DSCSA. For more information on what this law means to you as a pharmacy owner, manager or vendor check out; DSCSA.Pharmacy Thank you Bruce Kneeland for this interesting and needed discussion with Perry Fri. Listen on all #podcast directories or here: https://lnkd.in/eVkbKEkv

GLP-1 medications are a hot topic in health plans due to their high price tag and coverage complexity. It is also newsworthy for the general population because of their highly promoted weight loss success. Following up on ClearScript’s recent GLP-1 webinar, this podcast will answer some new questions and provide additional updates on this drug class. Listen now for answers to the pharmacy benefit questions everyone is talking about! https://lnkd.in/d6VMiazh #weightloss #generics #diabetes #GLP1 #pharmacy benefits #pbm #tpa #pharma #offlabeluse https://lnkd.in/gmMrM5af

NEW EPISODE ALERT: How did #PBMs evolve over 40 years from claims processors to the behemoths they are today? How did #pharma manufacturers go from owning PBMs to mortal enemies? How did PBMs go from lowering the cost of drugs to embracing #rebates and higher #drugprices? What gave rise to restricted #formularies and administrative burdens like #priorauthorizations? In this new episode, Scott Howell and I cover all this in our interview with two pharma #managedcare executives, Steve Stefano and Bill Leonard.  We also discuss the public scrutiny of PBMs, key trends shaping their future, and the changes needed to better serve #patients. Tune in for a comprehensive discussion on the past, present, and future of PBMs. Available here or on any podcast platform: https://lnkd.in/e7BG7eKh #PBM #marketaccess #PhRMA #healthcare #patientaccess